Hong Kong May Lower BioNTech Vaccine Age To 12
"); jQuery("#212 h3").html("

"); });
2021-06-02 HKT 00:38
The Department of Health on Tuesday said it had received an application from Fosun Pharma on Saturday to lower the minimum age for the Comirnaty vaccine to 12, along with phase three clinical trial data.
It said the information had been passed on to the advisory panel on Covid-19 vaccines and that the secretary for food and health would consider any suggestions.
The department said it expected a decision could be reached quickly.
The minimum age for the Comirnaty vaccine, provided by BioNTech and its Greater China partner Fosun Pharma, is 16 in the SAR.
The minimum age for the other vaccine used in Hong Kong, which is made by Sinovac, is 18.
StartmeupHK Festival And Hong Kong Fintech Week 2025 Merge For 10th Anniversary Milestone
Invest Hong Kong (InvestHK) announced on 10 March 2025 that both of its flagship events, Hong Kong Fintech Week 2025 an... Read more
Ant AI-Powered Health Insurance Processes 7.25M Claims In 2024, 55%YoY Increase
In 2024, Ant Insurance, the online insurance brokerage platform of Ant Group, processed 7.25 million health claims, mar... Read more
Ping An Talent Uses AI For Job Matching, But Can Technology Make Recruitment Fairer?
Ping An Insurance (Group) Company of China, Ltd. has launched its 2025 Spring Campus Recruitment, offering over 2,000 p... Read more
HKEX Partners With CMU OmniClear To Boost Post-Trade Securities Infrastructure
Hong Kong Exchanges and Clearing Limited (HKEX) announced on 4 March 2025 that it signed a Memorandum of Understanding ... Read more
PAObank Secures Insurance Agency Licence, Partners With Ping An And FWD Hong Kong
PAO Bank Limited (PAObank) has received its Insurance Agency Licence from the Insurance Authority and signed strategic ... Read more
IFAST Launches Self-Service Accounts For Hong Kong Family Offices
Fintech solutions provider iFAST HK launches self-service accounts in Hong Kong, catering to the growing demand for ind... Read more